Profiling and targeting of cellular bioenergetics: inhibition of pancreatic cancer cell proliferation.
Profiling and targeting of cellular bioenergetics: inhibition of pancreatic cancer cell proliferation.
复制标题
DOI:
10.1038/bjc.2014.272
复制
发表时间:
2014-07-08
影响因子:
8.8
通讯作者:
Kalyanaraman, B.
中科院分区:
文献类型:
--
作者:
Cheng, G.;Zielonka, J.;McAllister, D.;Tsai, S.;Dwinell, M. B.;Kalyanaraman, B.
关键词:
Targeting both mitochondrial bioenergetics and glycolysis pathway is an effective way to inhibit proliferation of tumour cells, including those that are resistant to conventional chemotherapeutics. In this study, using the Seahorse 96-well Extracellular Flux Analyzer, we mapped the two intrinsic cellular bioenergetic parameters, oxygen consumption rate and proton production rate in six different pancreatic cancer cell lines and determined their differential sensitivity to mitochondrial and glycolytic inhibitors. There exists a very close relationship among intracellular bioenergetic parameters, depletion of ATP and anti-proliferative effects (inhibition of colony-forming ability) in pancreatic cancer cells derived from different genetic backgrounds treated with the glycolytic inhibitor, 2-deoxyglucose (2-DG). The most glycolytic pancreatic cancer cell line was exquisitely sensitive to 2-DG, whereas the least glycolytic pancreatic cancer cell was resistant to 2-DG. However, when combined with metformin, inhibitor of mitochondrial respiration and activator of AMP-activated protein kinase, 2-DG synergistically enhanced ATP depletion and inhibited cell proliferation even in poorly glycolytic, 2-DG-resistant pancreatic cancer cell line. Furthermore, treatment with conventional chemotherapeutic drugs (e.g., gemcitabine and doxorubicin) or COX-2 inhibitor, celecoxib, sensitised the cells to 2-DG treatment. Detailed profiling of cellular bioenergetics can provide new insight into the design of therapeutic strategies for inhibiting pancreatic cancer cell metabolism and proliferation.
登录
查看更多内容
影响因子:
2.9
作者:
Deer EL;González-Hernández J;Coursen JD;Shea JE;Ngatia J;Scaife CL;Firpo MA;Mulvihill SJ
通讯作者:
Mulvihill SJ
影响因子:
2.9
作者:
Liu, H;Hu, YP;Lampidis, TJ
通讯作者:
Lampidis, TJ
影响因子:
4.5
作者:
Kung HN;Marks JR;Chi JT
通讯作者:
Chi JT
DOI:
10.1158/1078-0432.ccr-12-0041
发表时间:
2012-08-15
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Le A;Rajeshkumar NV;Maitra A;Dang CV
通讯作者:
Dang CV
影响因子:
11.2
作者:
Iliopoulos D;Hirsch HA;Struhl K
通讯作者:
Struhl K